Rouan Sarah Kathryn

CIK 00017613662 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001761366

Recent Transactions

30 trades

Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2026-01-02+20,400→ 20,400 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2026-01-02+3,150→ 4,390 total
Purchase
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2025-03-31$24.15/sh+1,240→ 1,240 total
Purchase
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2025-03-31$24.15/sh+1,240→ 1,240 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2025-01-02+18,800→ 18,800 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-10-25−11,000→ 11,000 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-10-25$4.88/sh+11,000→ 11,000 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-10-25$80.89/sh−11,000→ 0 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-02-08$8.32/sh+25,000→ 25,000 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-02-08−25,000→ 0 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-02-08$28.05/sh−25,000→ 0 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-01-19$8.32/sh+30,000→ 30,000 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-01-19$23.05/sh−30,000→ 0 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-01-19−30,000→ 25,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-01-02+32,000→ 32,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2023-01-03+22,000→ 22,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2022-01-03+22,000→ 22,000 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2021-06-30+4,892→ 18,242 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2021-01-13$0.00/sh+2,500→ 13,350 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option
2021-01-13$0.00/sh+2,500→ 2,500 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2021-01-04+22,000→ 22,000 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2020-02-06$0.00/sh+2,500→ 10,850 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option
2020-02-06$0.00/sh+2,500→ 7,500 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2020-01-02+22,000→ 22,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2019-07-01+55,000→ 55,000 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2019-05-17$1.46/sh+3,350→ 8,350 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2019-02-07$0.00/sh+50,000→ 100,000 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option
2019-02-07$0.00/sh+50,000→ 100,000 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option
2019-01-02$0.00/sh+50,000→ 50,000 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2019-01-02$0.00/sh+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350

SAN DIEGO, CA, 92121

View on SEC.gov